SCHEMBL6985394

SCHEMBL6985394

CC(OC(=O)CNc1ccc2c(c1)CCCN2C(=O)CCc1ccc(C#N)cc1)C(=O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
RAB9A P51151 2/20 0.40
FPR1 P21462 2/20 0.39
FPR2 P25090 2/20 0.39
TP53 P04637 2/20 0.39
NPC1 O15118 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GRM7 Q14831 1/20 0.37
TSHR P16473 2/20 0.37
MEN1 O00255 1/20 0.37
USP2 O75604 1/20 0.37
HPGD P15428 1/20 0.37
KMT2A Q03164 1/20 0.37
HSD17B10 Q99714 1/20 0.37
EP300 Q09472 2/20 0.37
NR3C1 P04150 1/20 0.37
YAP1 P46937 1/20 0.36
PARP1 P09874 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6981983 0.85 RAB9A (0.46) ALDH1A1RAB9AFPR1FPR2TP53
SCHEMBL6976282 0.83 TP53 (0.44) ALDH1A1RAB9AFPR1FPR2TP53
SCHEMBL6976631 0.81 HSD17B3 (0.46) ALDH1A1RAB9AFPR1FPR2TP53
SCHEMBL6985397 0.81 CA12 (0.42) ALDH1A1RAB9AFPR1FPR2TP53
SCHEMBL6983653 0.81 FPR1 (0.44) ALDH1A1RAB9AFPR1FPR2TP53
SCHEMBL6985377 0.80 RAB9A (0.62) ALDH1A1RAB9AFPR1FPR2TP53
SCHEMBL6984731 0.80 TP53 (0.45) ALDH1A1RAB9AFPR1FPR2TP53
SCHEMBL6986432 0.78 TP53 (0.48) ALDH1A1RAB9AFPR1FPR2TP53
SCHEMBL6986003 0.78 RAB9A (0.48) ALDH1A1RAB9AFPR1FPR2TP53
SCHEMBL6984804 0.78 KCNH2 (0.45) ALDH1A1FPR1FPR2TP53IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed